Bayer logo

Bayer

Last updated January 31, 2026
432
Innovation Areas
13,147
Inventors
104
Collaborations

Insufficient endogenous immune response: BayerRecent Research Landscape

Weak endogenous immune responses limit the efficacy of therapeutic interventions against pathogens or tumors. Enhancing the magnitude of immune signaling overcomes systemic tolerance and therapeutic resistance.